CC BY-NC-ND 4.0 · J Reconstr Microsurg Open 2019; 04(02): e92-e95
DOI: 10.1055/s-0039-3400245
Original Article
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Effect of Variable Injection Sites for Indocyanine Green Dye on the Success of Lymphaticovenular Anastomosis

1   Department of Plastic and Reconstructive Surgery, Osaka Medical College, Daigaku-cho, Takatsuki, Osaka, Japan
,
Hiroyuki Iwanaga
1   Department of Plastic and Reconstructive Surgery, Osaka Medical College, Daigaku-cho, Takatsuki, Osaka, Japan
,
Yuki Otsuki
1   Department of Plastic and Reconstructive Surgery, Osaka Medical College, Daigaku-cho, Takatsuki, Osaka, Japan
,
Koichi Ueda
1   Department of Plastic and Reconstructive Surgery, Osaka Medical College, Daigaku-cho, Takatsuki, Osaka, Japan
› Author Affiliations
Funding None.
Further Information

Publication History

07 July 2019

29 September 2019

Publication Date:
25 November 2019 (online)

Abstract

Background Indocyanine green lymphography (ICGL) allows more accurate visualization for lymphaticovenular anastomosis (LVA). However, the protocol for ICGL has not been established yet. We investigated how injection sites of ICG affect lymphography results by comparing ICGL images based on different injection sites on the same patients.

Methods Our hospital followed two ICGL protocols over time: ICG was injected into patients' 1st to 4th toe web spaces during 2013 to 2017 (Protocol 1), but into their lateral and medial ankles and 1st and 4th toe web spaces starting in 2018 (Protocol 2). Ten patients with secondary lymphedema who underwent LVA twice, using each protocol, were included in this study. We compared their results in detail and evaluated the effects of variable ICG injection sites.

Results The average period between patients' first and second LVAs was 506 days. In six patients, Protocol 2 detected new and additional linear findings that had not been detected by Protocol 1. Average reduction of lower limb circumferences after second LVAs (using Protocol 2) was 2.73 cm in patients who showed new linear findings, whereas those with no new findings showed little reduction.

Conclusion LVA based on ICG injections only into the dorsum of the foot can miss valuable findings. Variable ICG injection sites may improve detection of lymphatic flow and LVA efficacy.

 
  • References

  • 1 Unno N, Inuzuka K, Suzuki M. , et al. Preliminary experience with a novel fluorescence lymphography using indocyanine green in patients with secondary lymphedema. J Vasc Surg 2007; 45 (05) 1016-1021
  • 2 Narushima M, Yamamoto T, Ogata F, Yoshimatsu H, Mihara M, Koshima I. Indocyanine green lymphography findings in limb lymphedema. J Reconstr Microsurg 2016; 32 (01) 72-79
  • 3 Pecking AP, Albérini JL, Wartski M, Edeline V, Cluzan RV. Relationship between lymphoscintigraphy and clinical findings in lower limb lymphedema (LO): toward a comprehensive staging. Lymphology 2008; 41 (01) 1-10
  • 4 Suami H, Scaglioni MF. Anatomy of the lymphatic system and the lymphosome concept with reference to lymphedema. Semin Plast Surg 2018; 32 (01) 5-11
  • 5 Suami H. Lymphosome concept: anatomical study of the lymphatic system. J Surg Oncol 2017; 115 (01) 13-17
  • 6 Blum KS, Proulx ST, Luciani P, Leroux JC, Detmar M. Dynamics of lymphatic regeneration and flow patterns after lymph node dissection. Breast Cancer Res Treat 2013; 139 (01) 81-86